142 related articles for article (PubMed ID: 11884389)
21. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance.
Pol A; Luetterforst R; Lindsay M; Heino S; Ikonen E; Parton RG
J Cell Biol; 2001 Mar; 152(5):1057-70. PubMed ID: 11238460
[TBL] [Abstract][Full Text] [Related]
22. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the caveolin-3 gene: When are they pathogenic?
de Paula F; Vainzof M; Bernardino AL; McNally E; Kunkel LM; Zatz M
Am J Med Genet; 2001 Apr; 99(4):303-7. PubMed ID: 11251997
[TBL] [Abstract][Full Text] [Related]
24. Regulating c-Ras function. cholesterol depletion affects caveolin association, GTP loading, and signaling.
Kranenburg O; Verlaan I; Moolenaar WH
Curr Biol; 2001 Nov; 11(23):1880-4. PubMed ID: 11728312
[TBL] [Abstract][Full Text] [Related]
25. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
Hayashi YK; Matsuda C; Ogawa M; Goto K; Tominaga K; Mitsuhashi S; Park YE; Nonaka I; Hino-Fukuyo N; Haginoya K; Sugano H; Nishino I
J Clin Invest; 2009 Sep; 119(9):2623-33. PubMed ID: 19726876
[TBL] [Abstract][Full Text] [Related]
26. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
Woodman SE; Sotgia F; Galbiati F; Minetti C; Lisanti MP
Neurology; 2004 Feb; 62(4):538-43. PubMed ID: 14981167
[TBL] [Abstract][Full Text] [Related]
27. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains.
McEwen DP; Li Q; Jackson S; Jenkins PM; Martens JR
Mol Pharmacol; 2008 Mar; 73(3):678-85. PubMed ID: 18045854
[TBL] [Abstract][Full Text] [Related]
28. Caveolins and cellular cholesterol balance.
Ikonen E; Parton RG
Traffic; 2000 Mar; 1(3):212-7. PubMed ID: 11208104
[TBL] [Abstract][Full Text] [Related]
29. A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.
Pradhan BS; Prószyński TJ
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228026
[TBL] [Abstract][Full Text] [Related]
30. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation.
Liu YT; Song L; Templeton DM
J Cell Physiol; 2007 Apr; 211(1):205-12. PubMed ID: 17226785
[TBL] [Abstract][Full Text] [Related]
31. Connexin family members target to lipid raft domains and interact with caveolin-1.
Schubert AL; Schubert W; Spray DC; Lisanti MP
Biochemistry; 2002 May; 41(18):5754-64. PubMed ID: 11980479
[TBL] [Abstract][Full Text] [Related]
32. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
[TBL] [Abstract][Full Text] [Related]
33. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
[TBL] [Abstract][Full Text] [Related]
34. The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells.
Breuza L; Corby S; Arsanto JP; Delgrossi MH; Scheiffele P; Le Bivic A
J Cell Sci; 2002 Dec; 115(Pt 23):4457-67. PubMed ID: 12414992
[TBL] [Abstract][Full Text] [Related]
35. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
36. Caveolins bind to (Na+, K+)/H+ exchanger NHE7 by a novel binding module.
Lin PJ; Williams WP; Kobiljski J; Numata M
Cell Signal; 2007 May; 19(5):978-88. PubMed ID: 17207967
[TBL] [Abstract][Full Text] [Related]
37. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
[TBL] [Abstract][Full Text] [Related]
38. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease.
Quest AF; Leyton L; Párraga M
Biochem Cell Biol; 2004 Feb; 82(1):129-44. PubMed ID: 15052333
[TBL] [Abstract][Full Text] [Related]
39. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
[TBL] [Abstract][Full Text] [Related]
40. Membrane microdomains and caveolae.
Kurzchalia TV; Parton RG
Curr Opin Cell Biol; 1999 Aug; 11(4):424-31. PubMed ID: 10449327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
